N-hetaryformamidine-based dual IL-17 and IL-23 inhibitors for psoriasis and inflammatory skin disease treatment
Novel small molecule N-hetaryformamidine (HF) compounds that inhibit both IL-17 and IL-23 cytokine pathways for treating psoriasis and related inflammatory conditions. Initial screening shows potent IL-17 inhibition with...
Sustained-release postbiotic vaginal insert for anti-candida treatment
A novel sustained-release vaginal insert formulation utilizing postbiotics to combat recurrent vaginal yeast infections. The product aims to reduce antimicrobial resistance while providing soothing properties and synergi...
Simultaneous production of fatty acids and sugars from tropical microalgae
Innovative process using tropical microalgae to produce long-chain fatty acids and glucans under extreme conditions, utilizing industrial wastewater and CO2. Promises enhanced biochemical yields while reducing environmen...
Targeted probiotics delivery via dual encapsulation technology
This innovative dual encapsulation technology enables targeted probiotics release in the gastrointestinal tract. It features a pH-responsive outer shell, ensuring stability and efficacy, while minimizing taste impact in ...
Plant-derived peptide and organic acid antifungal agents
Innovative antifungal agents combining plant-derived peptides with organic acids for food-grade applications. This solution leverages synergistic effects for enhanced effectiveness against yeast and mold, offering a cost...
delivered to your inbox.